Reflecting on the Definitive TPD Forum 2026: Advancing the Future of Induced Proximity
With 6 tracks spanning Research Breakthroughs, Discovery, Preclinical Development, Translational and Clinical Development, Latest Tools & Technology and the Future of Induced Proximity, the summit served as a one-stop TPD shop for attendees to get up to speed with the latest platform technologies, accelerate R&D pipelines, validate novel ligases, and achieve clinical success for the next wave of proximity-based drugs.
Everyone who is anyone in the TPD field gathered once again under one roof. With 300+ attendees across academia, start‑ups, biotechs, pharma, and solution providers, the meeting provided direct access to the full TPD ecosystem. Attendees connected with leaders from Arvinas, Nurix Therapeutics, Monte Rosa Therapeutics, and more alongside pioneers unveiling novel platforms poised to transform the field.
Whether it was their first or ninth time attending this forum, attendees came together to tackle the challenges shaping key decisions, explore the tremendous opportunity TPD holds, and forge partnerships that will help patients with urgent unmet needs.
Brand New Companies that Attended in 2026
Key Highlights from 2026
Discovery Track
This track showcased novel cutting-edge platforms designed to unlock novel, previously undruggable targets, supported by rich in vitro and cell-based assay data. Attendees gained a comprehensive view of the next wave of degraders and actionable insights into accelerating discovery.
Speaking Companies Include:
Pre-Clinical Development Track
This track highlighted the most promising degrader candidates advancing through in vivo validation and lead optimization across oncology, inflammatory and CNS indications.
Speaking Companies Include:
Translational & Clinical Development Track
This track covered the latest translational and clinical data across degraders targeting oncology, autoimmune and CNS indications. Talks covered how a wide breadth of mechanisms from PROTACs to DACs and AUTOTACs– are showing meaningful patient outcomes and trailblazing the way for TPD.
Speaking Companies Include:
Explore the 2026 Full Event Guide
- 80+ World Class Speakers
- 4 Days of Exclusive Data-Driven TPD Content
- CXO and VC Panel Discussions
- Bespoke Networking & Partnering Opportunities
- The World’s Leading Event for the TPD & Induced Proximity Industry
Explore the 2026 Agenda
Explore tracks spanning Research Breakthroughs, Discovery, Preclinical Development, Translational and Clinical Development, Latest Tools & Technology and the Future of Induced Proximity.
Partner With Us
Position yourself alongside as the leading solution provider to ensure your brand is at the heart of TPD biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.